P5-Mouse Phenotyping
P5-Mouse Phenotyping
批准号:
8080387
负责人:
VAHRAM HAROUTUNIAN
金额:
$23.25万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2012-05-31
关键词:
AcousticsAcute Erythroblastic LeukemiaAddressAffectAgeAge-MonthsAgonistAmphetaminesAnimal ModelAnimalsAnisotropyAnteriorAntipsychotic AgentsAnxietyApomorphineAutopsyBehaviorBehavioralBiological ModelsBoxingBrainBrain regionCellsCellular biologyCognitiveCollaborationsComplexConsultationsCorpus striatum structureCoupledCyclic NucleotidesDevelopmentDopamineERBB2 geneEquilibriumEsthesiaEthylnitrosoureaEtiologyEvaluationEvolutionExposure toG-substrateGTP-Binding ProteinsGelsolinGene AbnormalityGene ExpressionGene ProteinsGenesGeneticGlutamate DecarboxylaseGlutamate ReceptorGrantHaloperidolHomologous GeneImageIndium-111IndividualKetamineKnock-outKnockout MiceLearningLocomotionMemoryMessenger RNAModelingModificationMolecularMotorMotor ActivityMusMutationMyelinMyelin Associated GlycoproteinMyelin ProteinsN-Methyl-D-Aspartate ReceptorsNeuroanatomyNeuronsOligodendrogliaParahippocampal GyrusPeripheralPersonsPharmaceutical PreparationsPhenotypePlayProteinsReagentReceptor SignalingReflex actionRegulationReportingResourcesRodent ModelRoleSchizophreniaScreening procedureSignal TransductionSocial InteractionSpecificitySpecimenStagingStructureSuperior temporal gyrusSynapsesSynapsin ITechniquesTestingTimeTransferrinUpdateViral OncogeneWorkbasebehavior influencebehavior testbrain tissuecingulate cortexgenetic associationin vivointerestlaser capture microdissectionmeetingsmolecular phenotypemouse modelmyelinationneurochemistryneuroimagingoligodendrocyte precursoroverexpressionphosphoric diester hydrolasepostsynaptic density proteinprecursor cellprepulse inhibitionprotein expressionputamenresearch studyresponsestereotypytranscription factorwhite matterworking groupyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project is dedicated to the development and characterization of mouse model systems that best reflect
the myelin and oligodendrocyte related (OMR) gene expression deficits in persons with schizophrenia.
Several different genetically modified mouse model systems will be evaluated (e.g., Quaking, MAG,
PTPRZ1, and Olig2. Each of these mouse model systems will be screened for deficits in the expression of
OMR genes using a panel of OMR genes that we have shown to be differentially affected in schizophrenia.
Those that evidence gene expression deficits on at least 3 OMR genes known to be affected in
schizophrenia will then be assessed for behavioral deficits. The behavioral phenotyping test battery will
include screening tests of simple (e.g., reflexes, locomotion, balance, sensation) as well as complex
(learning, memory, startle, prepulse inhibition of startle, social interaction, anxiety) behaviors. Coupled with
these purely behavioral tests will be pharmacological probes to ascertain whether pharmacological profiles
commonly viewed as prototypical for rodent models of schizophrenia are also evidenced by the OMR gene
deficient mice. Once "best-fit" model systems have been identified, they will be studied longitudinally to
ascertain the evolution of gene expression and behavioral deficits from 3 months of age through to 18
months of age. In addition, laser capture microdissection techniques will be employed to investigate gene
expression in identified cell groups. In collaboration with Project 1, the "best-fit" mouse model system will be
systematically imaged by DTI in vivo at ages corresponding to those for behavioral testing. In collaboration
with Project 3, brain tissue specimens from additional mice will be studied for changes in oligodendroglial
proliferation, differentiation and survival. Significant progress has already been made in this regard. All of
the behavioral test paradigms have been piloted and parameters have been optimized for use in mice in our
phenotyping facility (results and descriptions appended). Three of the 4 animal model systems proposed for
use (Quaking, Olig2, and MAG) have been obtained. Some studies have already been completed in these
mice and colonies have been established to enable more large scale studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIH BRAIN AND TISSUE RESPOSITORY (NBTR)
-
批准号:10916989
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2023
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease
-
批准号:10662733
-
项目类别:
-
资助金额:$243.82万
-
财政年份:2023
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Single-nucleus transcriptome profiling across multiple brain regions in Parkinson's Disease
-
批准号:10372330
-
项目类别:
-
资助金额:$209.96万
-
财政年份:2021
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
-
批准号:10302046
-
项目类别:
-
资助金额:$126.84万
-
财政年份:2021
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
-
批准号:10685326
-
项目类别:
-
资助金额:$126.75万
-
财政年份:2021
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
-
批准号:10495197
-
项目类别:
-
资助金额:$126.75万
-
财政年份:2021
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
-
批准号:10412322
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2020
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
-
批准号:10473437
-
项目类别:
-
资助金额:$134.73万
-
财政年份:2020
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
-
批准号:10685914
-
项目类别:
-
资助金额:$143.86万
-
财政年份:2020
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Neuropathology Core
-
批准号:10614010
-
项目类别:
-
资助金额:$27.53万
-
财政年份:2020
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
-
批准号:10643264
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2020
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
-
批准号:10565876
-
项目类别:
-
资助金额:$193.59万
-
财政年份:2020
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
-
批准号:10505723
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2020
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Neuropathology Core
-
批准号:10406872
-
项目类别:
-
资助金额:$24.25万
-
财政年份:2020
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
-
批准号:10362719
-
项目类别:
-
资助金额:$151.36万
-
财政年份:2020
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
-
批准号:10044164
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
-
批准号:10248273
-
项目类别:
-
资助金额:$55.51万
-
财政年份:2019
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
-
批准号:10030984
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
-
批准号:10248272
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2019
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位:
NIMH, NICHD, AND NINDS BRAIN AND TISSUE REPOSITORY
-
批准号:9332244
-
项目类别:
-
资助金额:$61.48万
-
财政年份:2016
-
负责人:VAHRAM HAROUTUNIAN
-
依托单位: